These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19445453)

  • 1. Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Zou MF; Cao J; Deschamps JR; Rodriguez AL; Conn PJ; Newman AH
    J Med Chem; 2009 Jun; 52(11):3563-75. PubMed ID: 19445453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications.
    Iso Y; Grajkowska E; Wroblewski JT; Davis J; Goeders NE; Johnson KM; Sanker S; Roth BL; Tueckmantel W; Kozikowski AP
    J Med Chem; 2006 Feb; 49(3):1080-100. PubMed ID: 16451073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5.
    Zhang P; Zou MF; Rodriguez AL; Conn PJ; Newman AH
    Bioorg Med Chem; 2010 May; 18(9):3026-35. PubMed ID: 20382541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
    Lea PM; Faden AI
    CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships for negative allosteric mGluR5 modulators.
    Kaae BH; Harpsøe K; Kvist T; Mathiesen JM; Mølck C; Gloriam D; Jimenez HN; Uberti MA; Nielsen SM; Nielsen B; Bräuner-Osborne H; Sauerberg P; Clausen RP; Madsen U
    ChemMedChem; 2012 Mar; 7(3):440-51. PubMed ID: 22267204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Newman AH
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2987-91. PubMed ID: 17446071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.
    Alagille D; DaCosta H; Chen Y; Hemstapat K; Rodriguez A; Baldwin RM; Conn PJ; Tamagnan GD
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3243-7. PubMed ID: 21546249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
    Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
    Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors.
    Yu M; Tueckmantel W; Wang X; Zhu A; Kozikowski AP; Brownell AL
    Nucl Med Biol; 2005 Aug; 32(6):631-40. PubMed ID: 16026710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
    Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Wållberg A; Bauer U; Hammerland LG; Peterson A; Svensson T; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4792-5. PubMed ID: 16839764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization and modeling of the binding sites of novel 1,3-bis(pyridinylethynyl)benzenes as metabotropic glutamate receptor 5-selective negative allosteric modulators.
    Mølck C; Harpsøe K; Gloriam DE; Clausen RP; Madsen U; Pedersen LØ; Jimenez HN; Nielsen SM; Mathiesen JM; Bräuner-Osborne H
    Mol Pharmacol; 2012 Nov; 82(5):929-37. PubMed ID: 22899869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced stress-induced hyperthermia in mGluR5 knockout mice.
    Brodkin J; Bradbury M; Busse C; Warren N; Bristow LJ; Varney MA
    Eur J Neurosci; 2002 Dec; 16(11):2241-4. PubMed ID: 12473093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
    Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.